Developing cardiovascular disease risk programs in India – Why location and wealth matter
Peiris D, Prabhakaran D
PLoS Med. Pub. online June 19, 2018.
Leggi
Breaking news
One-stop microvascular screening service: an effective model for the early detection of diabetic peripheral neuropathy and the high-risk foot
Binns-Hall O, Selvarajah D, Sanger D, et al.
Diabetic Medicine. 2018;35(7):887-94
Leggi
Renal effects of sacubitril/valsartan in patients with diabetes
Störk S
The Lancet Diabetes & Endocrinology. Pub. online July 2018.
Leggi
Type 2 diabetes mellitus in older people: a brief statement of key principles of modern day management including the assessment of frailty. A national collaborative stakeholder initiative
Strain WD, Hope SV, Green A, et al.
Diabetic Medicine. 2018;35(7):838-45
Leggi
Geographic and sociodemographic variation of cardiovascular disease risk in India: A cross-sectional study of 797,540 adults
Geldsetzer P, Manne-Goehler J, Theilmann M, et al.
PLoS Med. Pub. online June 19, 2018.
Leggi
Untangling the complications of diabetes – Editorial
Lancet 2018 16 Jun;391(10138):2389
Leggi
Self-management of diabetes in hospital: a guideline from the Joint British Diabetes Societies (JBDS) for Inpatient Care group
Flanagan D, Dhatariya K, Kilvert A, on behalf of the Joint British Diabetes Societies (JBDS) for Inpatient Care group and Guidelines writing group
Diabetic Medicine. Pub. online 19 June 2018.
Leggi
Association of Glycemic Control and Cell Stress With Telomere Attrition in Type 1 Diabetes
Tesovnik T, Kovač J, Hovnik T, et al.
JAMA Pediatr. Pub. online June 21.
Leggi
Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial
Tuttle KR, Lakshmanan MC, Rayner B ,et al.
Lancet Diabetes Endocrinol. Pub. online 14 June 2018.
Leggi
Sodium bicarbonate therapy for patients with severe metabolic acidaemia in the intensive care unit (BICAR-ICU): a multicentre, open-label, randomised controlled, phase 3 trial
Jaber S, Paugam C, Futier E, et al.
Lancet. Pub. online 14 June 2018
Leggi